Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9893)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 5, 2025 (publication date) through Nov 26, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Wickramasinghe N, Devanarayana NM. Insight into global burden of gastroesophageal reflux disease: Understanding its reach and impact. World J Gastrointest Pharmacol Ther 2025; 16(1): 97918 [PMID: 40094147 DOI: 10.4292/wjgpt.v16.i1.97918] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Wickramasinghe N, Devanarayana NM. Insight into global burden of gastroesophageal reflux disease: Understanding its reach and impact. World J Gastrointest Pharmacol Ther 2025; 16(1): 97918 [PMID: 40094147 DOI: 10.4292/wjgpt.v16.i1.97918] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v16/i1/97918.htm |
| Number | Citing Articles |
| 1 |
I. G. Bakulin, N. V. Bakulina, Yu. G. Topalova, S. V. Tikhonov, N. V. Pavlova. “GeFest” questionnaire: New diagnostic options for GERD and functional dyspepsia. Meditsinskiy sovet = Medical Council 2025; (15): 28 doi: 10.21518/ms2025-430
|
| 2 |
Xuemei Liu, Decheng Deng, Jian Meng, Haitang Hu, Quankun Zhuang, Xue Zhou, Long Fu, Binke Fan, Xueting Xu, Qin Huang, Xiaoyan Chen, Fang Hou. Pharmacokinetics, mass balance, and metabolism of the novel potassium-competitive acid blocker JP-1366 in healthy Chinese adults following a single oral dose of [14C]JP-1366. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1701581
|
| 3 |
Tingting Xu, Fuxing Wen, Jiayuan Zhao, Wei Zhang. Endoscopic Anti-Reflux Mucosal Interventions for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis of Efficacy, Safety, and Comparative Outcomes. Digestive Diseases 2025; : 1 doi: 10.1159/000548198
|
| 4 |
Hideki Mizuno, Shingo Inagaki, Kazutoshi Yamada, Shinji Kamiyamamoto. Follow-up study of vonoprazan maintenance therapy for reflux esophagitis: A 96-week evaluation in patients with PPI-refractory disease. Biomedical Reports 2025; 23(4): 1 doi: 10.3892/br.2025.2038
|
| 5 |
Xiao Longwu, Xia Teng. A socioeconomic perspective on the global burden of gastroesophageal reflux disease (1990–2021): findings from the GBD 2021. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04389-7
|